Hansa Biopharma AB
Developing innovative immunomodulating therapies for rare immunologic diseases.
Yleiskatsaus
- 100–199
- Työntekijät
- 50–100milj SEK
- Liikevaihto
- 2007
- Perustettu
Avainpäättäjät
Maria Törnsén
Chief Operating Officer and President U.S.
Hitto Kaufmann
Chief Scientific & Technology Officer
Richard Philipson
Chief Medical Officer
Eva Nilsagård
Member of the Board
+19 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Hansa Biopharma is a science-led biopharmaceutical company dedicated to empowering people living with rare immunologic diseases. They focus on developing innovative immunomodulating therapies designed to transform patient lives. The company leverages proprietary antibody-cleaving enzyme technology,...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556734535901
Päättäjät
23 yhteystietoa FunnelfeedrissäMaria Törnsén
Chief Operating Officer and President U.S.
Hitto Kaufmann
Chief Scientific & Technology Officer
Richard Philipson
Chief Medical Officer
Eva Nilsagård
Member of the Board
Renée Aguiar-Lucander
Chief Executive Officer
Brian Gorman
Chief Legal Officer and Corporate Secretary
Evan Ballantyne
Chief Financial Officer
Sandra Frithiof
Chief Human Resources Officer
Jonas Wikström
Member of the Board
Gina Ewy
Vice President of Global Market Access
Søren Tulstrup
President and CEO
Elisabeth Björk
Member of the Board
Michael Bologna
Member of the Board
Peter Nicklin
Chair of the Board
Mats Blom
Member of the Board
Kerstin Falck
Vice President Global Corporate Affairs
Natalie Berner
Member of the Board
Lena Winstedt
Global Franchise Lead, Gene Therapy
Anne Säfström Lanner
Senior Vice President and Chief Human Resources Officer
Hilary M. Malone
Member of the Board
Frank Bringstrup
Chief Regulatory Affairs Officer
Elisabeth Sonesson
Global Franchise Lead, Autoimmune
Angela Maldonado
Scientific Affairs Director
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
CHIESI PHARMA AB
International biopharmaceutical group focused on patient care and innovation.
ASTRAZENECA AS
105 työntekijätGlobal science-led pharmaceutical company delivering life-changing medicines across key areas.
Chiesi Pharma AB
50–99 työntekijätInternational biopharmaceutical group developing innovative therapeutic solutions globally.
Alexion Pharma Nordics AB
10–19 työntekijätPioneering transformative medicines for the global rare disease community.
ARGENX BV
1–4 työntekijätEngineering life-changing immunology solutions for severe autoimmune diseases.
Selaa lisää
Kysymyksiä yrityksestä Hansa Biopharma AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo